Works matching AU Lub-de Hooge, Marjolijn N.


Results: 76
    1

    Advances and challenges in immunoPET methodology.

    Published in:
    Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
    By:
    • Mohr, Philipp;
    • van Sluis, Joyce;
    • Hooge, Marjolijn N. Lub-de;
    • Lammertsma, Adriaan A.;
    • Brouwers, Adrienne H.;
    • Tsoumpas, Charalampos
    Publication type:
    Article
    2

    Advances and challenges in immunoPET methodology.

    Published in:
    Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
    By:
    • Mohr, Philipp;
    • van Sluis, Joyce;
    • Hooge, Marjolijn N. Lub-de;
    • Lammertsma, Adriaan A.;
    • Brouwers, Adrienne H.;
    • Tsoumpas, Charalampos
    Publication type:
    Article
    3

    Preclinical characterisation of 111In-DTPA-trastuzumab.

    Published in:
    British Journal of Pharmacology, 2004, v. 143, n. 1, p. 99, doi. 10.1038/sj.bjp.0705915
    By:
    • Lub-de Hooge, Marjolijn N.;
    • Kosterink, Jos G.W.;
    • Perik, Patrick J.;
    • Nijnuis, Hugo;
    • Tran, Ly;
    • Bart, Joost;
    • Suurmeijer, Albert J.H.;
    • de Jong, Steven;
    • Jager, Pieter L.;
    • de Vries, Elisabeth G.E.
    Publication type:
    Article
    4
    5

    <sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1715, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    6

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans Valentijn;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    7

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    8

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    9

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    10

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Molecular Imaging in Cancer Drug Development.

    Published in:
    Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 726, doi. 10.2967/jnumed.116.188045
    By:
    • Waaijer, Stijn J. H.;
    • Kok, Iris C.;
    • Eisses, Bertha;
    • Schröder, Carolina P.;
    • Jalving, Mathilde;
    • Brouwers, Adrienne H.;
    • Lub-de Hooge, Marjolijn N.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    45

    Theranostics Using Antibodies and Antibody-Related Therapeutics.

    Published in:
    Journal of Nuclear Medicine, 2017, v. 58, p. 83S, doi. 10.2967/jnumed.116.186940
    By:
    • Moek, Kirsten L.;
    • Giesen, Danique;
    • Kok, Iris C.;
    • de Groot, Derk Jan A.;
    • Jalving, Mathilde;
    • Fehrmann, Rudolf S. N.;
    • Lub-de Hooge, Marjolijn N.;
    • Brouwers, Adrienne H.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    46
    47
    48

    <sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1244, doi. 10.2967/jnumed.115.167643
    By:
    • Oosting, Sjoukje F.;
    • van Asselt, Sophie J.;
    • Brouwers, Adrienne H.;
    • Bongaerts, Alfons H.H.;
    • Steinberg, Julia D.J.;
    • de Jong, Johan R.;
    • Lub-de Hooge, Marjolijn N.;
    • van der Horst-Schrivers, Anouk N.A.;
    • Walenkamp, Annemiek M.E.;
    • Hoving, Eelco W.;
    • Sluiter, Wim J.;
    • Zonnenberg, Bernard A.;
    • de Vries, Elisabeth G.E.;
    • Links, Thera P.
    Publication type:
    Article
    49
    50